Erythromycin ethyl succinate 125mg/5ml oral suspension
BNF presentation 0501050H0AAAAAA within chapter Infections. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0501050H0AAAAAA
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
7,082
NHS spend (£)
£57,082.92
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 796 |
| February 2025 | 8 |
| December 2024 | 316 |
| November 2024 | 1,223 |
| October 2024 | 1,139 |
| September 2024 | 2 |
| August 2024 | 61 |
| July 2024 | 1,213 |
| May 2024 | 388 |
| July 2021 | 533 |
| June 2021 | 342 |
| December 2020 | 486 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 45 | No data available |
| Unknown pharmacy | 43 | No data available |
| Unknown pharmacy | 32 | No data available |
| Unknown pharmacy | 28 | No data available |
| Unknown pharmacy | 26 | No data available |
| Unknown pharmacy | 26 | No data available |
| Unknown pharmacy | 24 | No data available |
|
Wakering Medical Ctr.
ODS F81089
|
23 | 99F - MID AND SOUTH ESSEX ICB |
| Unknown pharmacy | 23 | No data available |
| Unknown pharmacy | 21 | No data available |